Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-29 @ 7:32 AM
Study NCT ID:
NCT05051033
Status:
RECRUITING
Last Update Posted:
2025-10-06
First Post:
2021-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008944', 'term': 'Mitral Valve Insufficiency'}], 'ancestors': [{'id': 'D006349', 'term': 'Heart Valve Diseases'}, {'id': 'D006331', 'term': 'Heart Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D058386', 'term': 'Mitral Valve Annuloplasty'}], 'ancestors': [{'id': 'D058385', 'term': 'Cardiac Valve Annuloplasty'}, {'id': 'D006348', 'term': 'Cardiac Surgical Procedures'}, {'id': 'D013504', 'term': 'Cardiovascular Surgical Procedures'}, {'id': 'D013514', 'term': 'Surgical Procedures, Operative'}, {'id': 'D019616', 'term': 'Thoracic Surgical Procedures'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Eligible and consented patients will be randomized 1:1 to a TEER versus surgical repair. Patient randomization will be stratified by clinical site and by surgical risk profile, namely low, intermediate, and high surgical risk. Primary effectiveness will be analyzed by intention-to-treat; that is, the patients will be grouped by their assignment at randomization whether or not they actually received the treatment to which they were assigned.'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 450}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2022-02-21', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-10', 'completionDateStruct': {'date': '2030-11-15', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-10-03', 'studyFirstSubmitDate': '2021-09-10', 'studyFirstSubmitQcDate': '2021-09-10', 'lastUpdatePostDateStruct': {'date': '2025-10-06', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2021-09-21', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2028-11-15', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'All-cause mortality, valve re-intervention, hospitalizations and urgent visits for heart failure, or onset of ≥ 2+ MR (by transthoracic echocardiogram (TTE)) composite score.', 'timeFrame': '3 years post intervention', 'description': "Composite score of all-cause mortality, valve re-intervention, hospitalizations and urgent visits for heart failure, or onset of ≥ 2+ MR (by transthoracic echocardiogram (TTE)) from randomization to a minimum follow-up of 3 years post randomization (including a one-month post intervention blanking period for HF hospitalizations/urgent visits).\n\nComposite score will be expressed as a Z-score - The Z-Score is a statistical measurement of a score's relationship to the mean in a group of scores. A Z-score of 0 is equal to the mean, with negative numbers indicating values lower than the mean and positive values higher than the mean."}], 'secondaryOutcomes': [{'measure': 'Adequacy of MR correction', 'timeFrame': 'one year post intervention', 'description': 'Adequacy of MR correction at one year post intervention, defined as \\< 2+ MR as assessed by TTE'}, {'measure': 'Kansas City Cardiomyopathy Questionnaire (KCCQ)', 'timeFrame': 'up to 10 years post intervention', 'description': 'Disease-specific quality of life as measured by the KCCQ at 6-month time intervals up to 5 years. KCCQ has 23 items that map to 7 domains: symptom frequency; symptom burden; symptom stability; physical limitations; social limitations; quality of life; and self-efficacy. The symptom frequency and symptom burden domains are merged into a total symptom score, which can be combined with the physical limitation domain to create a clinical summary score. All scores are scaled 0 to 100, with higher scores indicating better health outcome.'}, {'measure': 'Procedure failure', 'timeFrame': 'End of procedure', 'description': 'Procedure failure defined as residual moderately severe or severe (3+ or 4+/4+) MR at the end of the procedure, or conversion of a TEER to an open surgical repair or replacement, or conversion of a surgical mitral valve repair to a mitral valve replacement procedure.'}, {'measure': 'Procedure failure', 'timeFrame': '10 years post randomization', 'description': 'Procedure failure defined as residual moderately severe or severe (3+ or 4+/4+) MR at the end of the procedure, or conversion of a TEER to an open surgical repair or replacement, or conversion of a surgical mitral valve repair to a mitral valve replacement procedure.'}, {'measure': 'All-cause mortality', 'timeFrame': '5 years post randomization', 'description': 'All-cause mortality through 5 years post randomization'}, {'measure': 'All-cause mortality', 'timeFrame': '10 years post intervention', 'description': 'All-cause mortality from randomization through 10 years post intervention'}, {'measure': 'Cardiovascular and non-cardiovascular mortality', 'timeFrame': '5 years post intervention', 'description': 'Cardiovascular and non-cardiovascular mortality from randomization through 5 years post intervention'}, {'measure': 'Cardiovascular and non-cardiovascular mortality', 'timeFrame': '10 years post intervention', 'description': 'Cardiovascular and non-cardiovascular mortality from randomization through 10 years post intervention'}, {'measure': 'Valve re-interventions', 'timeFrame': '5 years post intervention', 'description': 'Valve re-interventions through 5 years post intervention'}, {'measure': 'Valve re-interventions', 'timeFrame': '10 years post intervention', 'description': 'Valve re-interventions through 10 years post intervention'}, {'measure': 'Serious or protocol-defined adverse events', 'timeFrame': '5 years post intervention', 'description': 'Serious or protocol-defined adverse events, including stroke, acute kidney injury (AKI), and renal failure, through 5 years'}, {'measure': 'MR grade', 'timeFrame': 'up to 5 years post intervention', 'description': 'Mitral Regurgitation (MR) grade as mild, moderate, or severe. (grade I-IV, with higher grade indicating poorer health outcomes.)'}, {'measure': 'Left Ventricular Ejection Fraction (LVEF)', 'timeFrame': 'up to 5 years post intervention', 'description': 'Left ventricular ejection fraction (LVEF) is the measurement of how much blood is being pumped out of the left ventricle of the heart (the main pumping chamber) with each contraction.'}, {'measure': 'Left Ventricular End Diastolic Dimension (LVEDD)', 'timeFrame': 'up to 5 years post intervention', 'description': 'Left ventricular end diastolic dimension (LVEDD) is the diameter across the left ventricle of the heart at the end of diastole, that is, when the heart muscle is maximally relaxed, and usually corresponds to its largest diameter.'}, {'measure': 'Left Ventricular End Systolic Dimension (LVESD)', 'timeFrame': 'up to 5 years post intervention', 'description': 'Left ventricular end systolic dimension (LVESD) is the diameter across the left ventricle of the heart at the end of systole, that is, when the heart muscle is maximally contracted, and usually corresponds to its smallest diameter.'}, {'measure': 'Left Ventricular End Diastolic Volume (LVEDV)', 'timeFrame': 'up to 5 years post intervention', 'description': 'Left Ventricular end diastolic volume (LVEDV) is the volume of blood in the left ventricle at the end of the diastole or ventricular filling.'}, {'measure': 'Left Ventricular End Systolic Volume (LVESV)', 'timeFrame': 'up to 5 years post intervention', 'description': 'Left Ventricular end systolic volume (LVESV) is the volume of blood in the left ventricle at the end of the systolic ejection phase immediately before the beginning of diastole or ventricular filling.'}, {'measure': 'Mitral valve gradient', 'timeFrame': 'up to 5 years post intervention', 'description': 'The valve gradient is the difference in pressure on each side of the valve. When a valve is narrowed (a condition called stenosis), the pressure on the front of the valve builds up as blood is forced through the narrow opening. This causes a larger pressure difference between the front and back of the valve. The valve gradient can be used to determine the severity of the valve disorder.'}, {'measure': 'Forward stroke volume', 'timeFrame': 'up to 5 years post intervention', 'description': 'The forward stroke volume is the volume entering the aorta.'}, {'measure': '6 Minute Walk Test (6MWT)', 'timeFrame': 'up to 5 years post intervention', 'description': 'Functional status as measured by the 6MWT at yearly time intervals over 5 years. 6MT - The distance covered over a time of 6 minutes'}, {'measure': 'EuroQol- 5 Dimension (EQ-5D)', 'timeFrame': 'through 10 years post intervention', 'description': 'Generic QoL as measured by the EuroQol-5D (EQ-5D). The EQ-5D descriptive system is a preference-based HRQL measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The answers given to ED-5D permit to find 243 unique health states or can be converted into EQ- 5D index an utility scores anchored at 0 for death and 1 for perfect health. The EQ-5D questionnaire also includes a Visual Analog Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).'}, {'measure': 'Length of stay (LOS)', 'timeFrame': 'through 10 years post intervention', 'description': 'Length of stay as measured by number of days hospitalized.'}, {'measure': 'ICU days of index hospitalization', 'timeFrame': 'through 10 years post intervention', 'description': 'Number of ICU days of index hospitalization'}, {'measure': 'Number and reasons for readmissions', 'timeFrame': 'through 10 years post intervention', 'description': 'Number and reasons for readmissions, including for valve re-intervention and readmissions/urgent visits for heart failure'}, {'measure': 'Cost', 'timeFrame': 'through 10 years post intervention', 'description': 'Costs associated with the index hospitalization as well as follow-up readmissions will be measured.'}, {'measure': 'Cost-effectiveness', 'timeFrame': 'through 10 years post intervention', 'description': 'A cost-effectiveness analysis (CEA) comparing cumulative costs and quality-adjusted life years (QALYs) of transcatheter edge-to-edge repair vs surgical repair will be performed from U.S., Canadian, German and United Kingdom health care sector perspectives according to national guidelines.'}, {'measure': 'Number of participants with stroke with disability', 'timeFrame': '30 days post-intervention', 'description': 'Stroke with disability is defined as a modified Rankin score of ≥ 2 and/or major bleeding (BARC Type 3b, 3c and 5) by 30 days post-intervention'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'keywords': ['surgical mitral valve repair', 'transcatheter edge-to-edge repair'], 'conditions': ['Mitral Valve Regurgitation']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://clinicaltrials.gov/study/NCT07103733', 'label': 'PRIMARY Ancillary Substudy'}]}, 'descriptionModule': {'briefSummary': 'This is a prospective, multicenter, open-label, randomized trial comparing mitral valve (MV) transcatheter edge-to-edge repair (TEER) to surgical repair (1:1 ratio) in patients with primary, degenerative mitral regurgitation (MR). The trial will be conducted in the U.S., Canada, Germany, Spain, Belgium and the United Kingdom, and is designed as a strategy trial. Thus, all devices legally marketed for TEER of primary degenerative MR in a particular country are eligible to be used in this trial.', 'detailedDescription': 'The primary aim of this study is to evaluate the long-term effectiveness and safety of MV TEER compared with surgical repair in patients with primary, degenerative MR. The secondary aim is to analyze the relationship between the adequacy of MR correction at one-year post intervention and longer-term clinical outcomes (death, heart failure hospitalizations/urgent care visits, valve re-interventions, and quality of life). The tertiary aim of this trial is to evaluate a range of patient-centered outcomes (quality of life, functional status, and discharge location) of transcatheter edge-to-edge MV repair compared with MV surgical repair in patients with primary, degenerative mitral regurgitation. This study is closely integrated with the PRIMARY Ancillary Substudy (NCT07103733)\n\nThe patient population for this trial consists of adult patients with severe, primary degenerative MR for whom the local heart team has verified that an indication for MV intervention is present and for whom both transcatheter edge-to-edge and surgical repair strategies are anatomically feasible.\n\nBecause the use of the commercial edge-to-edge mitral repair device in the U.S. is approved only in patients considered to be at prohibitive risk of MV surgery by a heart team, use of such devices in this trial is considered investigational by the FDA. As such, this trial will be conducted under an Investigational Device Exemption (IDE).\n\nOutcomes will be measured from randomization over a period of 5 years post intervention. The estimated enrollment period is 36 months, and all patients will be followed from randomization for up to 10 years post intervention for particular endpoints. Long-term follow-up will include leveraging administrative datasets linked to clinical trial data.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '60 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'The patient population for this trial consists of adults with severe, primary degenerative MR for whom the local heart team has verified that an indication for MV intervention is present and for whom both transcatheter edge-to-edge and surgical repair strategies are anatomically feasible. Specific inclusion and exclusion criteria are listed below. All patients who meet eligibility criteria will be included in the study regardless of gender, race, or ethnicity.\n\nInclusion Criteria:\n\n* Adult patients ≥60 yrs with moderately-severe or severe (3+ or 4+/4+) primary degenerative (Carpentier type II) MR defined by transthoracic echocardiography\n* Clinical indication for MV intervention and anatomic candidate for both MV transcatheter edge-to-edge and surgical repair per local heart team assessment\n* Patients across the surgical risk spectrum (low, intermediate, and high risk) depending on the local heart team assessment (see 2020 ACC/AHA guidelines for the management of patients with valvular heart disease)\n* Patients with AF who meet an indication for concomitant ablation may be included provided the local heart team verifies they are eligible for both catheter-based and surgical ablation.\n* Ability to perform 6-minute walk test (6MWT) and complete Kansas City Cardiomyopathy Questionnaire (KCCQ) instrument\n\nExclusion Criteria:\n\n* Non-degenerative types of primary MR (e.g., cleft leaflet)\n* Secondary or functional MR\n* Hypertrophic obstructive cardiomyopathy\n* Presence of an IVC filter or pacing/ICD leads that would interfere with TEER per local heart team assessment\n* Known allergic reactions to intravenous contrast\n* Febrile illness within 30-days prior to randomization\n* Any absolute contraindication to transesophageal echocardiography\n* Any contraindication to systemic heparinization including active bleeding diatheses, and heparin induced thrombocytopenia\n* Patients with CAD requiring revascularization\n* Any prior mitral valve intervention or any prior repair of atrial septal defect\n* Any prior MV intervention or any prior repair of atrial septal defect\n* Need for any of the following concomitant procedures: aortic valve or aortic surgery, tricuspid valve surgery\n* Need for any emergency intervention or surgery\n* Active endocarditis\n* Hemodynamic instability defined as cardiac index \\<2.0 l/min/m2 or systolic blood pressure \\<90mmHg or need for inotropic support or any mechanical circulatory support\n* Left ventricular ejection fraction \\<25%\n* Intracardiac mass or thrombus\n* Co-morbid medical or oncologic condition for which local heart team believes that meaningful survival beyond 2 years is unlikely\n* Active substance abuse\n* Suspected inability to adhere to follow-up\n* Treatment with another investigational drug or other intervention, assessment of which has not completed its primary endpoint or that clinically interferes with the present study endpoints.'}, 'identificationModule': {'nctId': 'NCT05051033', 'acronym': 'PRIMARY', 'briefTitle': 'Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)', 'organization': {'class': 'OTHER', 'fullName': 'Icahn School of Medicine at Mount Sinai'}, 'officialTitle': 'Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)', 'orgStudyIdInfo': {'id': 'STUDY-21-01246'}, 'secondaryIdInfos': [{'id': '5U01HL088942', 'link': 'https://reporter.nih.gov/quickSearch/5U01HL088942', 'type': 'NIH'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Surgical mitral valve repair', 'description': 'Patients who are randomized to the surgical arm will undergo mitral surgery.', 'interventionNames': ['Procedure: Mitral valve repair']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Transcatheter edge-to-edge repair', 'description': 'In the transcatheter edge-to-edge repair arm, patients will be treated with a commercially-approved edge-to-edge mitral repair device.', 'interventionNames': ['Device: Transcatheter edge-to-edge repair']}], 'interventions': [{'name': 'Mitral valve repair', 'type': 'PROCEDURE', 'otherNames': ['Mitral valve surgery'], 'description': 'Patients who are randomized to the surgical arm will undergo mitral surgery. Mitral surgery will be conducted using general anesthesia and cardiopulmonary bypass. Mitral surgery may be performed via a sternotomy or a right thoracotomy approach with or without robotic assistance. Standard techniques commonly include a ring or band annuloplasty to correct and prevent annular dilatation; leaflet prolapse and redundancy may be corrected by leaflet resection techniques and / or chordal reconstruction.', 'armGroupLabels': ['Surgical mitral valve repair']}, {'name': 'Transcatheter edge-to-edge repair', 'type': 'DEVICE', 'otherNames': ['TEER'], 'description': "Patients will be treated with a commercially-approved edge-to-edge mitral repair device. The steerable guide catheter (guide) is inserted into the femoral vein and advanced across the inter-atrial septum using image guided puncture. Fluoroscopic and echocardiographic guidance will be used to visualize the devices and assess the repair. The guide is positioned over the MV and the clip/clasp delivery system is inserted into the guide and positioned over the MV in accordance with the manufacturer's instructions. The delivery catheter is advanced until the clip/clasp emerges from the tip of the guide into the left atrium. The catheter is manipulated using the control handle until the clip/clasp is correctly oriented with respect to the line of coaptation of the mitral valve. The clip/clasp is opened, and advanced across the mitral valve into the left ventricle then pulled back to grasp the leaflets.", 'armGroupLabels': ['Transcatheter edge-to-edge repair']}]}, 'contactsLocationsModule': {'locations': [{'zip': '90033', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Edward Lozano', 'role': 'CONTACT', 'email': 'edwardlo@med.usc.edu'}, {'name': 'Vaughn Starnes, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Keck Hospital of the University of Southern California', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90048', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Joanna Chikwe, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cedars Sinai Medical Center', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '94143', 'city': 'San Francisco', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Georgia Applegarth', 'role': 'CONTACT'}, {'name': 'Sammy Elmariah, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of California San Francisco', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '94305', 'city': 'Stanford', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Luz Memije', 'role': 'CONTACT', 'email': 'memije16@stanford.edu'}, {'name': 'Jack Boyd, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Stanford University', 'geoPoint': {'lat': 37.42411, 'lon': -122.16608}}, {'zip': '30309', 'city': 'Atlanta', 'state': 'Georgia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Danielle Griffith', 'role': 'CONTACT'}, {'name': 'Vinod Thourani, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Piedmont Heart Institute', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30322', 'city': 'Atlanta', 'state': 'Georgia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Sonya Matheson', 'role': 'CONTACT', 'email': 'sbmathe@emory.edu'}, {'name': 'Michael Halkos, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Emory University', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '70121', 'city': 'New Orleans', 'state': 'Louisiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Nicole Scholl', 'role': 'CONTACT', 'email': 'Nicolle.scholl@ochsner.org'}, {'name': 'E. Patrick Parrino, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ochsner Clinic', 'geoPoint': {'lat': 29.95465, 'lon': -90.07507}}, {'zip': '04102', 'city': 'Portland', 'state': 'Maine', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Betsey Gallant', 'role': 'CONTACT', 'email': 'Betsey.Gallant@mainehealth.org'}, {'name': 'Robert Kramer, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Maine Medical Center', 'geoPoint': {'lat': 43.65737, 'lon': -70.2589}}, {'zip': '21287', 'city': 'Baltimore', 'state': 'Maryland', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Lisa Fornaresio, PhD', 'role': 'CONTACT', 'email': 'lisa.fornaresio@jhmi.edu'}, {'name': 'James Gammie, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Johns Hopkins Hospital', 'geoPoint': {'lat': 39.29038, 'lon': -76.61219}}, {'zip': '02114', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Patrick Udeh', 'role': 'CONTACT', 'email': 'pudeh@mgh.harvard.edu'}, {'name': 'Serguei Melnitchouk, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Massachusetts General Hospital', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02115', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Mark Cunningham, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Brigham and Women's", 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '48109', 'city': 'Ann Arbor', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Nicole White', 'role': 'CONTACT', 'email': 'nlaniece@med.umich.edu'}, {'name': 'Gorav Ailawadi, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Michigan Hospital', 'geoPoint': {'lat': 42.27756, 'lon': -83.74088}}, {'zip': '64111', 'city': 'Kansas City', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Diane Peterman, RN, BSN, CCRC', 'role': 'CONTACT', 'email': 'Dpeterman@saint-lukes.org'}, {'name': 'Keith Allen, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Saint Luke's Hospital of Kansas City/MidAmerica Heart and Lung Surgeons", 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '03756', 'city': 'Lebanon', 'state': 'New Hampshire', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Prezley Duncan, MS', 'role': 'CONTACT', 'email': 'Prezley.M.Duncan@hitchcock.org'}, {'name': 'Jock McCullough, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dartmouth Hitchcock Medical Center', 'geoPoint': {'lat': 43.64229, 'lon': -72.25176}}, {'zip': '10032', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Olutobi Adewale', 'role': 'CONTACT', 'email': 'oa2386@cumc.columbia.edu'}, {'name': 'Isaac George, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Nyph/Cumc', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10065', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Marshagay Rodrigues', 'role': 'CONTACT', 'email': 'mar4028@med.cornell.edu'}, {'name': 'Stephanie Mick, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Weill Cornell Medicine/ New York-Presbyterian Hospital', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '21287', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Ameerah Ali, PA-C, MBA', 'role': 'CONTACT', 'email': 'aali35@northwell.edu'}, {'name': 'Nirav Patel, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Northwell Health', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '27710', 'city': 'Durham', 'state': 'North Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Kathleen Lane', 'role': 'CONTACT', 'email': 'kathleen.rohrback@duke.edu'}, {'name': 'Donlad Glower, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Duke University Hospital', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '44195', 'city': 'Cleveland', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Anna M Simmons', 'role': 'CONTACT', 'email': 'SIMMONA8@ccf.org'}, {'name': 'Marc Gillinov, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cleveland Clinic', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'zip': '19104', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Mary Lou Mayer, RN, BSN', 'role': 'CONTACT', 'email': 'MaryLou.Mayer@pennmedicine.upenn.edu'}, {'name': 'Michael A Acker, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital of the University of Pennsylvania', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '29425', 'city': 'Charleston', 'state': 'South Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Stephanie Schorr', 'role': 'CONTACT', 'email': 'schorr@musc.edu'}, {'name': 'Marc Katz, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Medical University of South Carolina', 'geoPoint': {'lat': 32.77632, 'lon': -79.93275}}, {'zip': '75246', 'city': 'Dallas', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Molly Szerlip, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Baylor, Scott and White', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '22903', 'city': 'Charlottesville', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Nicole Sprouse', 'role': 'CONTACT', 'email': 'NJB6M@hscmail.mcc.virginia.edu'}, {'name': 'Linda Bryceland', 'role': 'CONTACT', 'email': 'lgs2m@hscmail.mcc.virginia.edu'}, {'name': 'Scott Lim, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Kenan Yount, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Virginia Medical Center', 'geoPoint': {'lat': 38.02931, 'lon': -78.47668}}, {'zip': '26506', 'city': 'Morgantown', 'state': 'West Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Josh Bombard', 'role': 'CONTACT', 'email': 'josh.bombard@wvumedicine.org'}, {'name': 'Vinay Badhwar, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'West Virginia University Hospital', 'geoPoint': {'lat': 39.62953, 'lon': -79.9559}}, {'zip': 'BC V6E 1M7', 'city': 'Vancouver', 'state': 'British Columbia', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Elizabeth Grieve', 'role': 'CONTACT', 'email': 'egrieve@providencehealth.bc.ca'}, {'name': 'Robert Boone', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "University of British Columbia, Providence Health Care, St. Paul's Hospital", 'geoPoint': {'lat': 49.24966, 'lon': -123.11934}}, {'zip': 'ON N6A 5W9', 'city': 'London', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Stephen Mardell', 'role': 'CONTACT'}, {'name': 'Michael Chu, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'London Health Sciences', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'zip': 'K1Y 4W7', 'city': 'Ottawa', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Alice Black', 'role': 'CONTACT', 'email': 'AlBlack@ottawaheart.ca'}, {'name': 'Vincent Chan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University of Ottawa Heart Institute', 'geoPoint': {'lat': 45.41117, 'lon': -75.69812}}, {'zip': 'M5B 1W8St', 'city': 'Toronto', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Ivana Kandic', 'role': 'CONTACT', 'email': 'Ivana.Kandic@unityhealth.to'}, {'name': 'Neil Fam', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Unity Health Toronto (St. Michael's Hospital)", 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'QC G1V 4G5', 'city': 'Québec', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Annie Bergeron', 'role': 'CONTACT', 'email': 'annie.bergeron@criucpq.ulaval.ca'}, {'name': 'Charles Laurin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (Laval University)', 'geoPoint': {'lat': 46.81228, 'lon': -71.21454}}, {'zip': '50969', 'city': 'Cologne', 'state': 'Berlin-kölnische Allee', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Vera Wolf', 'role': 'CONTACT', 'email': 'vera.wolf@uk-koeln.de', 'phone': '(0)221 47832592'}, {'name': 'Lenard Conradi', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Köln', 'geoPoint': {'lat': 50.93333, 'lon': 6.95}}, {'zip': '32545', 'city': 'Bad Oeynhausen', 'state': 'North Rhine-Westphalia', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Katja Schönefeld', 'role': 'CONTACT', 'email': 'KSchoenefeld@hdz-nrw.de', 'phone': '(0)5731 97 3897'}, {'name': 'René Schramm', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Herz- und Diabeteszentrum NRW', 'geoPoint': {'lat': 52.20699, 'lon': 8.80365}}, {'zip': '61231', 'city': 'Bad Nauheim', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Anett Kirchhof', 'role': 'CONTACT', 'email': 'a.kirchhof@kerckhoff-fgi.de', 'phone': '(0)6032 9966781'}, {'name': 'Yeong-Hoon Choi', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kerckhoff Klinik Bad Nauheim', 'geoPoint': {'lat': 50.36463, 'lon': 8.73859}}, {'zip': '49214', 'city': 'Bad Rothenfelde', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Birgit Wichter, RN, PhD', 'role': 'CONTACT', 'email': 'BWichter@schuechtermann-klinik.de', 'phone': '+49 (0)5424 641124'}, {'name': 'Nicolas Doll', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Schüchtermann-Klinik Bad Rothenfelde', 'geoPoint': {'lat': 52.11667, 'lon': 8.16667}}, {'zip': '13353', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Andreas Bader-Wölfle, RN, PhD', 'role': 'CONTACT', 'email': 'andreas.bader-woelfle@dhzc-charite.de', 'phone': '49 (0)30 4593 2204'}, {'name': 'Volkmar Falk', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Deutsches Herzzentrum der Charité', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '60590', 'city': 'Frankfurt', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Heike Strohschnitter', 'role': 'CONTACT', 'email': 'strohschnitter@med.uni-frankfurt.de', 'phone': '49 (0)69 63013724'}, {'name': 'Thomas Walther', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Frankfurt', 'geoPoint': {'lat': 49.68333, 'lon': 10.53333}}, {'zip': '79106', 'city': 'Freiburg im Breisgau', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Gabriele Lechner', 'role': 'CONTACT', 'email': 'gabriele.lechner@uniklinik-freiburg.de', 'phone': '(0)761 27061960'}, {'name': 'Wolfgang Bothe', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Freiburg', 'geoPoint': {'lat': 47.9959, 'lon': 7.85222}}, {'zip': '20099', 'city': 'Hamburg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Patrice Ouattara', 'role': 'CONTACT', 'email': 'p.ouattara@asklepios.com', 'phone': '+49 (0)40 1818854093'}, {'name': 'Samer Hakmi', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Asklepios Klinik St. Georg Hamburg', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '20246', 'city': 'Hamburg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Edda Matindas', 'role': 'CONTACT', 'email': 'e.matindas@uke.de', 'phone': '+49 (0)40 741052868'}, {'name': 'Lenard Conradi', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Simon Pecha', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Hamburg Eppendorf', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '69120', 'city': 'Heidelberg', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Myriam Wittek', 'role': 'CONTACT', 'email': 'Myriam.Wittek@med.uni-heidelberg.de', 'phone': '+49 (0)6221 5634814'}, {'name': 'Mathias Konstandin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Heidelberg', 'geoPoint': {'lat': 49.40768, 'lon': 8.69079}}, {'zip': '07747', 'city': 'Jena', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Sabine Krauspe', 'role': 'CONTACT', 'email': 'Sabine.Krauspe@med.uni-jena.de', 'phone': '+49 (0)3641 9322956'}, {'name': 'Torsten Doenst', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Jena', 'geoPoint': {'lat': 50.92878, 'lon': 11.5899}}, {'zip': '24105', 'city': 'Kiel', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Andrea Koch', 'role': 'CONTACT', 'email': 'Andrea.Koch@uksh.de', 'phone': '+49 (0)431 50022917'}, {'name': 'Derk Frank', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Schleswig-Holstein Campus Kiel', 'geoPoint': {'lat': 54.32133, 'lon': 10.13489}}, {'zip': '04289', 'city': 'Leipzig', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Josephin Kister', 'role': 'CONTACT', 'email': 'Josephin.Kister@helios-health-institute.com', 'phone': '+49 (0)341 865251551'}, {'name': 'Michael Borger', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Herzzentrum Leipzig', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '23538', 'city': 'Lübeck', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Alexandra Gottschalk, RN, PhD', 'role': 'CONTACT', 'email': 'Alexandra.Gottschalk@uksh.de', 'phone': '+49 (0)451 50044667'}, {'name': 'Stephan Ensminger', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Universitätsklinikum Schleswig-Holstein Campus Lübeck', 'geoPoint': {'lat': 53.86893, 'lon': 10.68729}}, {'zip': '80636', 'city': 'München', 'status': 'RECRUITING', 'country': 'Germany', 'contacts': [{'name': 'Felix Wirth', 'role': 'CONTACT', 'email': 'wirth@dhm.mhn.de', 'phone': '+49 (0)89 12182973'}, {'name': 'Konstantinos Sideris', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Deutsches Herzzentrum München', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '36204', 'city': 'Vigo', 'state': 'Galacia', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'name': 'Maria Garcia Donday', 'role': 'CONTACT', 'email': 'mgarcia@bcccbarcelona.cat'}, {'name': 'Rodrigo Estévez, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Juan José Legarra Calderón, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Alvaro Cunqueiro', 'geoPoint': {'lat': 42.23282, 'lon': -8.72264}}, {'zip': '08036', 'city': 'Barcelona', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'name': 'Maria Garcia Donday', 'role': 'CONTACT', 'email': 'mgarcia@bcccbarcelona.cat'}, {'name': 'Xavier Freixa, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Daniel Pereda, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Clinic De Barcelona', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '28040', 'city': 'Madrid', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'name': 'Maria Garcia Donday', 'role': 'CONTACT', 'email': 'mgarcia@bcccbarcelona.cat'}, {'name': 'Luis Nombela, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Javier Cobiella, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Clínico San Carlos', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '33011', 'city': 'Oviedo', 'status': 'RECRUITING', 'country': 'Spain', 'contacts': [{'name': 'Maria Garcia Donday', 'role': 'CONTACT', 'email': 'mgarcia@bcccbarcelona.cat'}, {'name': 'Alberto Alperi, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}, {'name': 'Jacobo Silva, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Hospital Central de Asturias', 'geoPoint': {'lat': 43.36029, 'lon': -5.84476}}, {'zip': 'CB2 0AY', 'city': 'Cambridge', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Patrick Calvert, BMBCh, MA, PhD, FRCP', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Royal Papworth Hospital NHS Foundation Trust', 'geoPoint': {'lat': 52.2, 'lon': 0.11667}}, {'zip': 'LS1 3EX', 'city': 'Leeds', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Chris Malkin, MBChB, MRCP, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Leeds Teaching Hospitals NHS Trust', 'geoPoint': {'lat': 53.79648, 'lon': -1.54785}}, {'zip': 'SE1 7EH', 'city': 'London', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center stees.acu@nhs.net', 'role': 'CONTACT'}, {'name': 'Tiffany Patterson, BSc, MBBS, PhD, MRCP', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "St. Thomas Guy's and St Thomas' NHS Foundation Trust", 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SE5 9RS', 'city': 'London', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Jonathan Byrne, MBChB, PhD, FRCP', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "King's College Hospital NHS Foundation Trust", 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'SW3 6NP', 'city': 'London', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Tony DeSouza, BMedSci, BMBS, MD, FRCS (CTh)', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "Royal Brompton and Harefield Guy's and St Thomas' NHS Foundation Trust", 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'M23 9LT', 'city': 'Manchester', 'state': 'England', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stess.acu@nhs.net'}, {'name': 'Mamta Buch, MBChB, PhD, FRCP', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Manchester University NHS Foundation Trust', 'geoPoint': {'lat': 53.48095, 'lon': -2.23743}}, {'zip': 'BN2 5BE', 'city': 'Worthing', 'state': 'West Sussex', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Ishtiaq Ahmed, BSc, MBChB, PhD, FRCS', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University Hospitals Sussex NHS Foundation Trust', 'geoPoint': {'lat': 50.81795, 'lon': -0.37538}}, {'zip': 'B15 2TH', 'city': 'Birmingham', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Adnan Nadir, MBBS, MD, MRCP', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University Hospitals Birmingham NHS Foundation Trust', 'geoPoint': {'lat': 52.48142, 'lon': -1.89983}}, {'zip': 'G81 4DY', 'city': 'Clydebank', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Angie Ghattas, MBChB, MRCP, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Golden Jubilee University National Hospital', 'geoPoint': {'lat': 55.90137, 'lon': -4.4057}}, {'zip': 'OX3 9DU', 'city': 'Headington', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Rana Sayeed, BMBCh, PhD, MRCP, FRCS (CTh)', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Oxford University Hospitals NHS Foundation Trust', 'geoPoint': {'lat': 51.75737, 'lon': -1.21974}}, {'zip': 'E1 8PR', 'city': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Dincer Aktuerk, PhD, FRCS (CTh)', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Barts Health NHS Trust', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'zip': 'TS4 3BW', 'city': 'Middlesbrough', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Enoch Akowuah, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'South Tees Hospitals NHS Foundation Trust', 'geoPoint': {'lat': 54.57623, 'lon': -1.23483}}, {'city': 'Middlesbrough', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'South Tees General Center', 'role': 'CONTACT', 'email': 'stees.acu@nhs.net'}, {'name': 'Paul Williams, BMBCh, MA, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'South Tees Hospital NHS Foundation Trust', 'geoPoint': {'lat': 54.57623, 'lon': -1.23483}}], 'centralContacts': [{'name': 'Chari Ponder, RN, BSN', 'role': 'CONTACT', 'email': 'chari.ponder@mountsinai.org', 'phone': '(646) 899-8106'}], 'overallOfficials': [{'name': 'Joanna Chikwe, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Cedars Sinai'}, {'name': 'Martin Leon, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Columbia University'}, {'name': "Patrick O'Gara, MD", 'role': 'STUDY_DIRECTOR', 'affiliation': "Brigham and Women's Hospital"}]}, 'ipdSharingStatementModule': {'url': 'https://biolincc.nhlbi.nih.gov/studies/', 'infoTypes': ['STUDY_PROTOCOL', 'SAP', 'ICF'], 'timeFrame': 'De-identified study data sets must be submitted to the designated NHLBI Program Official no later than 3 years after the end of the clinical activity (final patient follow-up, etc.) or 2 years after the main paper of the trial has been published, whichever comes first. Data are prepared by the study coordinating center and sent to the designated PO for review prior to release.', 'ipdSharing': 'YES', 'description': 'Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).', 'accessCriteria': 'Anyone who wishes to access the data. Any purpose. Data are available indefinitely at link included in the URL field below.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Annetine Gelijns', 'class': 'OTHER'}, 'collaborators': [{'name': 'National Heart, Lung, and Blood Institute (NHLBI)', 'class': 'NIH'}], 'responsibleParty': {'type': 'SPONSOR_INVESTIGATOR', 'investigatorTitle': 'Chair, Department of Population Health Science & Policy Edmond A. Guggenheim Professor of Health Policy Co-Director, InCHOIR', 'investigatorFullName': 'Annetine Gelijns', 'investigatorAffiliation': 'Icahn School of Medicine at Mount Sinai'}}}}